To help offer the best experience possible, Guilford uses cookies on its site. By browsing here, you acknowledge our terms of use. For more information, see our Cookie Policy.
You can also read Guilford's Privacy Policy.

Skip to main content

        All Access Pass: All Guilford journals, $49.95 for 30 days | Click on any article to purchase

The metacognitive model of psychological disorders is described and data on outcome and processes related to Metacognitive Therapy (MCT) are summarized. Data from uncontrolled and controlled trials are encouraging, as MCT appears to generally be an acceptable and effective treatment, and highly effective for patients with Generalized Anxiety Disorder, in particular. MCT leads to change in metacognition, and metacognition also predicts outcome in other treatment modalities. The theoretical issue of mental modes and how these might relate to conceptualization of treatment effects is discussed, as are recent applications of MCT to new patient populations. Areas for future research are provided, with a focus on the implications of the metacognitive model for understanding the origins of biased mental control and the effect of attachment relationships.